Drug Development

In addition to ensuring that Amgen's investment decisions are based on compelling science, we are reengineering our processes to operate...

At Amgen, we believe drug discovery starts with a deep understanding of biology. This understanding guides the critical choice of...

At a time when technological breakthroughs are revolutionizing how drugs are discovered, Amgen's strategy aims to fully exploit the emerging...

Many companies in our industry have pursued a strategy known as "Shots on Goal," where the aim is to maximize...

Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, and Boehringer Ingelheim (BI) announced today that they have...

Boehringer Ingelheim and Circuit Therapeutics have entered into a research collaboration agreement for the discovery of new ways of treating...

Crystal Bioscience Inc. (Crystal) and Boehringer Ingelheim announced today that they have entered into an agreement to collaborate on the...

Hydra Biosciences, Inc., a leader in the field of Transient Receptor Potential (TRP) channel modulation, and Boehringer Ingelheim, one of...

Connexios Life Sciences, a Bangalore based biotechnology company, and Boehringer Ingelheim, one of the world's leading pharmaceutical companies, today announced...

This year's Boehringer Ingelheim FENS Award was granted to Judit Makara from the Institute of Experimental Medicine of the Hungarian...